Displaying One Session

Janssen - Expanding horizons for the targeted management of EGFR-Positive NSCLC (ID 119)

Time
18:45 - 20:15

Welcome and introductions (ID 4848)

Disease progression in patients with common EGFR mutations (ID 4849)

Precision diagnostic and therapeutic approaches for EGFR exon 20 insertions (ID 4850)

Key learnings and closing remarks (ID 4851)

Live Q&A (ID 4852)